“insomniaare”的搜索结果，显示 131-140 项，共有 7615 项

1. 传染病- 临床试验- 妙佑医疗国际

   This study is being conducted to determine gene and protein expression profiles (i.e. which genes and proteins are turned off and on) of those with a ...

2. 神经科- 临床试验- 妙佑医疗国际

   ... are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non-cyclical therapy, collection should be at least 2.5-3.0 ...

3. 肺科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate plasma biomarkers of vascular function and inflammation in patients with newly-diagnosed Obstructive Sleep Apnea (OSA) ...

4. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

5. 神经科- 临床试验- 妙佑医疗国际

   ... are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non-cyclical therapy, collection should be at least 2.5-3.0 ...

6. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Constipation is a very common problem. Western style toilets that are nearly universal in the United States require the person to sit on the toilet. However, ...

7. 神经科- 临床试验- 妙佑医疗国际

   ... are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non-cyclical therapy, collection should be at least 2.5-3.0 ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... sleep assessed using PROMIS Sleep disturbance 7a form (1 week after surgery). ... The primary objectives are to determine the maximum tolerated dose (MTD) ...

9. 泌尿科- 临床试验- 妙佑医疗国际

   Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND. Rare ...

10. 脑肿瘤项目- 临床试验- 妙佑医疗国际

    ... are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non-cyclical therapy, collection should be at least 2.5-3.0 ...